Cargando…
Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trial
INTRODUCTION: In the multisystem inflammatory disorder systemic sclerosis (SSc), gastrointestinal tract (GIT) affliction is highly prevalent. There are no known disease modifying therapies and the negative impact is substantial. Aiming for a new therapeutic principle, and inspired by recent work sho...
Autores principales: | Hoffmann-Vold, Anna-Maria, Fretheim, Håvard H, Sarna, Vikas K, Barua, Imon, Carstens, Maylen N, Distler, Oliver, Khanna, Dinesh, Volkmann, Elizabeth R, Midtvedt, Øyvind, Didriksen, Henriette, Dhainaut, Alvilde, Halse, Anne-Kristine, Bakland, Gunnstein, Pesonen, Maiju, Olsen, Inge, Molberg, Øyvind |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231046/ https://www.ncbi.nlm.nih.gov/pubmed/34168032 http://dx.doi.org/10.1136/bmjopen-2020-048541 |
Ejemplares similares
-
Differential sensitivity of the 2020 revised comprehensive diagnostic criteria and the 2019 ACR/EULAR classification criteria across IgG4-related disease phenotypes: results from a Norwegian cohort
por: Vikse, Jens, et al.
Publicado: (2023) -
Effects of faecal microbiota transplantation on the small intestinal mucosa in systemic sclerosis
por: Strahm, Noemi, et al.
Publicado: (2023) -
Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohort
por: Fretheim, Håvard, et al.
Publicado: (2020) -
Target organ expression and biomarker characterization of chemokine CCL21 in systemic sclerosis associated pulmonary arterial hypertension
por: Didriksen, Henriette, et al.
Publicado: (2022) -
Serum markers of cardiac complications in a systemic sclerosis cohort
por: Tennøe, Anders H., et al.
Publicado: (2022)